Get Well Soon! Tina Knowles-Lawson Hospitalized Over the Weekend After Asthma … – Essence.com


Essence.com

Get Well Soon! Tina Knowles-Lawson Hospitalized Over the Weekend After Asthma
Essence.com
Tina Knowles-Lawson was hospitalized in Atlanta over the weekend after she suffered an asthma attack. The 61-year-old newlywed was in town for an awards show with her hubby, Richard Lawson, when she fell ill. "I came to Atlanta with my hubby for an …
Tina Knowles Lawson Hospitalized In AtlantaMadame Noire
Beyoncé's mother, Tina Lawson, hospitalizedRolling Out
Beyoncé's mother Tina Knowles Lawson hospitalized in Atlantaatlantadailyworld

all 4 news articles »

View full post on asthma – Google News

Asthma drugs market in the US to grow at a CAGR of 4.64% over the period … – Medgadget.com (blog)

Asthma drugs market in the US to grow at a CAGR of 4.64% over the period
Medgadget.com (blog)
Asthma is a disease that affects the lungs and is characterized by wheezing, coughing, breathlessness, and chest tightness. It is a chronic ailment of the respiratory tract, which is caused by the obstruction of the flow of air and bronchospasms, where

and more »

View full post on asthma – Google News

Asthma treatment less effective in patients over 30 – Times of India


Times of India

Asthma treatment less effective in patients over 30
Times of India
"Asthma morbidity and mortality are known to be increased in middle-aged and older patients, and gender may also affect the incidence and course of the disease, but the impact of age and gender on asthma treatment response is not well understood.
Treatment less effective in asthma patients over 30The Indian Express

all 7 news articles »

View full post on asthma – Google News

Treatment less effective in asthma patients over 30 – The Indian Express


The Indian Express

Treatment less effective in asthma patients over 30
The Indian Express
Older patients with asthma are at increased risk for treatment failure, particularly those patients being treated with inhaled steroids, says a new study. “Asthma morbidity and mortality are known to be increased in middle-aged and older patients, and
Asthma treatment less effective in patients over 30Zee News

all 5 news articles »

View full post on asthma – Google News

ProPublica: Safety questions over GSK’s Advair linger after years on the … – FiercePharma

ProPublica: Safety questions over GSK's Advair linger after years on the
FiercePharma
Recent research suggests that a significant percentage of asthma patients begin using Advair inappropriately, the watchdog says, and that can trigger the "risk of asthma-related death" described on the med's label. And while the FDA in 2010 required

and more »

View full post on asthma – Google News

World Asthma Day 2015: How Asthma Will Be Treated Over The Next 10 Years … – Medical Daily


Medical Daily

World Asthma Day 2015: How Asthma Will Be Treated Over The Next 10 Years
Medical Daily
World Asthma Day is an international effort to raise awareness about asthma in order to improve asthma care throughout the world. Each year the Global Initiative for Asthma organizes a theme, but this year's will continue the same focus on control

View full post on asthma – Google News

Bad air day sparks alert over asthma – The Times (subscription)


The Times (subscription)

Bad air day sparks alert over asthma
The Times (subscription)
Britain has been placed on a health alert because of a cloud of pollution blowing in from Europe that could cause fatal asthma attacks. Officials have urged asthmatics, elderly people and children to be cautious because of air blowing in from the
Toxic smog hits UK: Air pollution health alert is set trigger asthma attacks mirror.co.uk
The KILLER SMOG is BACK: Toxic pollution cloud from Europe to smother Express.co.uk
Asthma suffers warned over heavy air pollution hitting ScotlandHerald Scotland
WalesOnline –Scottish Daily Record –The Guardian
all 56 news articles »

View full post on asthma – Google News

GSK, Theravance’s Breo Faces Scrutiny Over Safety for Asthma – Bloomberg


Reuters

GSK, Theravance's Breo Faces Scrutiny Over Safety for Asthma
Bloomberg
(Bloomberg) — GlaxoSmithKline Plc and Theravance Inc.'s respiratory drug Breo Ellipta will face questions from a regulatory panel over the safety of expanding its use to treat asthma patients and whether it's suitable for children. Advisers to the U.S
FDA staff finds no new safety problems with Glaxo's asthma drugReuters
GSK Studies Found No Asthma Deaths For COPD Drug, FDA SaysLaw360 (subscription)
New Glaxo asthma treatment reviewed by FDANational Monitor

all 25 news articles »

View full post on asthma – Google News